|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
Related companies:
Azenta US, Inc |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
Related companies:
Artivion, Inc. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
Related companies:
Azenta US, Inc |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
Related companies:
Spyre Therapeutics, Inc. |
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
|
| Read more ›› |
|
By: PR Newswire Association LLC. - 01 Apr 2024
|
|
Related companies:
Eupraxia Pharmaceuticals Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Akari Therapeutics Plc |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Trevena, Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Axsome Therapeutics, Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Xtant Medical |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Apellis Pharmaceuticals, Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Shattuck Labs, Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Microbix Biosystems Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Fractyl Health, Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Venus Concept Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Milestone Scientific, Inc. |
|
|
| Read more ›› |
|
By: GlobeNewswire - 01 Apr 2024
|
|
Related companies:
Algernon Pharmaceuticals Inc. |
|
|
